HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma

Mostrar otras versiones (1)

Glioma is the most common and aggressive tumor type of the central nervous system and is associated with poor prognosis. To date, novel emerging immunotherapies have significantly improved outcomes for patients with various cancer types. Human endogenous retrovirus-H long terminal repeat-associating...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yangzhi, Deng, Gang, Xu, Pengfei, Zhang, Huikai, Yuan, Fanen, Geng, Rongxin, Jiang, Hongxiang, Liu, Baohui, Chen, Qianxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826309/
https://www.ncbi.nlm.nih.gov/pubmed/31578594
http://dx.doi.org/10.3892/or.2019.7343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826309/
https://www.ncbi.nlm.nih.gov/pubmed/31578594
http://dx.doi.org/10.3892/or.2019.7343

Ejemplares similares